Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter, Prospective, Non-interventional Cohort Study to Evaluate the Safety of Oral Resin for Treatment of Hyperkalemia in Chinese Patients With Renal Insufficiency

NCT05462119 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT05462119
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05462119 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter, Prospective, Non-interventional Cohort Study to Evaluate the Safety of Oral Resin for Treatment of Hyperkalemia in Chinese Patients With Renal Insufficiency
Lead sponsor
AstraZeneca
Phase
Observational
Overall status
Completed
Start date
August 22, 2022
Completion date
December 29, 2023
Enrollment
887 (actual)
Sites
16

Conditions

As the registry lists them; a condition with its own page is linked.

hyperkalaemia